CCK

6 Item(s)

per page

Set Descending Direction
  1. Proglumide

    Catalog No. A18171
    Quick View
    CCK antagonist
    Proglumide is a drug that exerts an inhibitory effect on gastric secretion and reduces gastrointestinal motility. IProglumide is a known cholecystokinin (CCK) antagonist. Learn More
  2. Dexloxiglumide

    Catalog No. A18541
    Quick View
    CCKA receptor antagonist
    Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8). Learn More
  3. Loxiglumide (CR1505)

    Catalog No. A11769
    Quick View
    CCK-A receptor antagonist
    Loxiglumide (CR1505) is a cholecystokinin antagonist Learn More
  4. Proglumide sodium salt

    Catalog No. A13713
    CCK antagonist
    Proglumide sodium salt is a non-selective cholecystokinin (CCK) antagonist. It inhibits CCK-stimulated amylase secretion and prevents CCK-induced 2-deoxyglucose uptake in mouse pancreatic acini. Learn More
  5. Z-360 calcium salt (Nastorazepide calcium salt)

    Catalog No. A13671
    Quick View
    CCK-2 receptor antagonist
    Z-360 is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Learn More
  6. Nastorazepide (Z-360)

    Catalog No. A15984
    Quick View
    CCK-2 receptor antagonist
    Nastorazepide is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Learn More

6 Item(s)

per page

Set Descending Direction
Rewards